✦ LIBER ✦

Nd:YAG laser in the treatment of epistaxis in hereditary hemorrhagic telangiectasia

✍ Scribed by Hassan H. Ramadan

Book ID: 117402272
Publisher: SAGE Publications
Year: 1996
Tongue: English
Weight: 210 KB
Volume: 115
Category: Article
ISSN: 0194-5998
DOI: 10.1016/s0194-5998(96)80912-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nd-YAG Laser Photocoagulation for Epista

Nd-YAG Laser Photocoagulation for Epistaxis Associated with Hereditary Hemorrhagic Telangiectasia

✍ Elizabeth J. Mahoney; Stanley M. Shapshay 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Treatment of hereditary hemorrhagic tela

Treatment of hereditary hemorrhagic telangiectasia by ND-YAG laser photocoagulation

✍ Stanley M. Shapshay; Peter Oliver 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

Topical timolol for the treatment of epi

Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia

✍ Scott E. Olitsky 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Management of epistaxis in hereditary he

Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire

✍ Ilias Karapantzos; Nikolaos Tsimpiris; Dimitrios G. Goulis; Helen Hoecke; Paul C 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 179 KB

The natural history of epistaxis in here

The natural history of epistaxis in hereditary hemorrhagic telangiectasia

✍ O. Sami Aassar; Craig M. Friedman; Robert I. White Jr. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The effect of bevacizumab (Avastin) trea

The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

✍ Jana Simonds; Frank Miller; Jess Mandel; Terence M. Davidson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract ## Objectives/Hypothesis: Determine the effectiveness of treating epistaxis in hereditary hemorrhagic telangiectasia (HHT) with potassium titanyl phosphate (KTP) laser cautery combined with submucosal injection of 100 mg of bevacizumab. ## Study Design: Retrospective pilot study. ##